Scientific Consultant, Senior Vice President, Chief Scientific Officer and a Co-Founder of NOX Technologies, Inc.
Prof. Dorothy Morre received her doctorate from Purdue University in Nutrition and Neurobiology and joined the faculty in 1978. She was promoted to Professor in 1989. Prof. Morré serves on the Board of Directors of NOX Technologies, Inc. as Senior Vice President and Chief Scientific Officer. She currently serves the project to provide expertise especially in the areas of cell culture and cellular aspects of antibody production and characterization.
Dr. Morre has been singularly involved in the discovery and development of the ECTO-NOX (ENOX) family of proteins, especially the cancer (tumor)-specific tNOX (ENOX2) and its various isoforms as well as development of the considerable intellectual property upon which NOX Technologies, Inc. is founded.
Dr. Dorothy M. Morré Professor of Foods and Nutrition Department of Foods and Nutrition Purdue University 700 West State Street, Room G1E West Lafayette, IN 47907-2059 Phone: (765) 494-8233 FAX: (765) 494-0906 Email: morredm@purdue.edu
SELECTED PUBLICATIONS OF PROF. DOROTHY M. MORRÉ
Axanova, L., D. J. Morré and D. M. Morré. 2005. Growth of LNCaP cells in monoculture and coculture with osteoblasts and response to tNOX inhibitors. Cancer Letters 225: 35-40.
Cooper, R., D. J. Morré and D. M. Morré. 2005. Medicinal benefits of green tea. Part II: Review of anticancer properties. J. Alt. Comp. Med.. 11:639-652.
Morré, D.M. and D. J. Morré. 2006. Catechin-vanilloid synergies with potential clinical applications in cancer. Rejuvenation Research 9:45-55.
Morré, D.J. and D. M. Morré. 2006. Aging-related cell surface ECTO-NXO protein, arNOX, a preventive target to reduce atherogenic risk in the elderly. Rejuvenation Research 9:231-236.
Morré, D.M. and D. J. Morré. 2006. Anticancer activity of grape and grape skin extracts alone and combined with green tea infusions. Cancer Letters 238:202-209.
Jiang, Z., D. M. Morré and D. J. Morré. 2006. A role for copper in biological time-keeping. J. Inorg. Biochem. 100: 2140-2149.
Yagiz, K., L.-Y. Wu, C.P. Kuntz, D. J. Morré and D. M. Morré. 2007. Mouse embryonic fibroblast cells from transgenic mice overexpressing tNOX express an altered growth and drug response phenotype. J. Cell. Biochem. 101: 295-306.
Tang, X., Z. Tian, P.-J. Chueh, S. Chen, D. M. Morré and D. J. Morré. 2007. Alternative splicing as the basis for specific localization of tNOX, a unique hydroquinone (NADH) oxidase, to the cancer cell surface. Biochemistry 46: 12,337-12,346.
Weaver, C. M., S. Barnes, J. M. Wyss, H. Kim, D. M. Morré, D. J. Morré, J. E. simon, M. A. Lila, E. M. Janle and M. G. Ferruzzi. 2007. Botanicals for age-related diseases: from field to practice. American J. Cancer Nutr. Suppl. 2007.